Skip to main content
SpringerLink
Log in

Early Renal Hyperfunction and Hypertrophy in IDDM Patients Including Comments on Early Intervention

  • Chapter
The Kidney and Hypertension in Diabetes Mellitus

Abstract

Since diabetic nephropathy constitutes the principal background for reduced survival in insulin-dependent diabetes, much interest is being paid to early alterations in kidney function and structure, and to the possible relationship between such early abnormalities and later development of diabetic nephropathy. A modest increase in urinary albumin excretion, microalbuminuria, has been identified as an early marker of diabetic nephropathy, and interventions postponing the onset of overt nephropathy has been introduced. In this chapter the earliest renal changes in IDDM, glomerular hyperfunction and renal hypertrophy, will be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91–100.

    Article  PubMed  CAS  Google Scholar 

  2. Ditzel J, Schwartz M. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 1976; 16: 264–267.

    Google Scholar 

  3. Chnstensen JS, Gammelgaard J, Frandsen M, Parving H-H. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 1981; 20: 451–456.

    Google Scholar 

  4. Brøchner-Mortensen J, Ditzel J. Glomerular filtration rate and extracellular fluid volume in insulin-dependent patients with diabetes mellitus. Kidney Int 1982; 21: 696–698.

    Article  PubMed  Google Scholar 

  5. Hansen KW, Mau Pedersen M, Chnstensen CK, Schmitz A, Christiansen JS, Mogensen CE. Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J Intern Med 1992; 232: 161–167.

    Article  PubMed  CAS  Google Scholar 

  6. Mogensen CE. Kidney function and glomerular permeability to macromolecules in juvenile diabetes. Dan Med Bull 1972; 19: 1–36.

    PubMed  Google Scholar 

  7. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving H-H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–688.

    Article  PubMed  CAS  Google Scholar 

  8. Nyberg G, Granerus G, Aurell M. Renal extraction ratios for 51Cr-EDTA, PAH, and glucose in early insulin-dependent diabetic patients. Kidney Int 1982; 21: 706–708.

    Article  PubMed  CAS  Google Scholar 

  9. Chnstensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 1985; 2: 97–102.

    Article  Google Scholar 

  10. Mogensen CE, Chnstensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.

    Article  PubMed  CAS  Google Scholar 

  11. Ellis EN, Steffes MW, Coetz FC, Sutherland DER, Mauer SM. Glomerular filtration surface in type 1 diabetes mellitus. Kidney Int 1986; 29: 889–894.

    Article  PubMed  CAS  Google Scholar 

  12. Christiansen JS, Frandsen M, Parving H-H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20: 199–204.

    PubMed  CAS  Google Scholar 

  13. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706–713.

    PubMed  CAS  Google Scholar 

  14. Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment. Diabetologia 1975; 11: 221–224.

    Article  PubMed  CAS  Google Scholar 

  15. Puig JG, Anton FM, Grande C, Pallardo LF, Arnalich F, Gil A, Vázquez JJ, Garcia AM. Relation on kidney size to kidney function in early insulin-dependent diabetes. Diabetologia 1981; 21: 363–367.

    Article  Google Scholar 

  16. Schwieger J, Fine LG. Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin Nephrol 1990; 10: 242–253.

    PubMed  CAS  Google Scholar 

  17. Feldt-Rasmussen B, Hegedüs L, Mathiesen ER, Deckert T. Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control. Scand J Lab Invest 1991; 51: 31–36.

    CAS  Google Scholar 

  18. Østerby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus: I. Early abnormalities. Diabetologia 1975; 11: 225–229.

    Article  PubMed  Google Scholar 

  19. Seyer-Hansen K, Hansen J, Gundersen HJG. Renal hypertrophy in experimental diabetes: a morphometric study. Diabetologia 1980; 18: 501–505.

    Article  PubMed  CAS  Google Scholar 

  20. Tuttle KR, Bruto JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626–1532.

    Article  PubMed  CAS  Google Scholar 

  21. Wisemann MJ, Saunders AJ, Keen H, Viberti GC. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312: 617–621.

    Article  Google Scholar 

  22. Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving H-H. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985; 34: 1301–1305.

    Article  PubMed  CAS  Google Scholar 

  23. Wolpert HA, Kinsley BT, Clermont AC, Wald H, Bursell S-E. Hyperglycaemia modulates retinal hemodynamics in IDDM. Diabetes 1993; 42: A489.

    Google Scholar 

  24. Gray SD. Effect of hypertonicity on vascular dimensions in skeletal muscle. Microvasc Res 1971; 3: 117–124.

    Article  PubMed  CAS  Google Scholar 

  25. Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40: 792–807.

    Article  PubMed  CAS  Google Scholar 

  26. Harvey JN, Edmundson AW, Jaffa AA, Martin LL, Mayfield RK. Renal excretion of kallikrein and eicosanoids in patients with Type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia 1992; 35: 857–862.

    Article  PubMed  CAS  Google Scholar 

  27. Perico N, Benigni A, Gabanelli M, Piccinelli A, Rog M, De-Riva C, Remuzzi G. Atrial natriuretide peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 1992; 41: 533–538.

    Article  PubMed  CAS  Google Scholar 

  28. Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycemia on tubuloglomerular feedback activity. Kidney Int 1982; 22: S206–S212.

    Google Scholar 

  29. Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest 1971; 28: 177–182.

    Article  PubMed  CAS  Google Scholar 

  30. Christiansen JS, Frandsen M, Parving H-H. Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia 1981; 21: 368–373.

    Article  PubMed  CAS  Google Scholar 

  31. Mathiesen ER, Gall M-A, Hommel E, Skøtt P, Parving H-H. Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabetic Med 1989; 6: 595–600.

    Article  PubMed  CAS  Google Scholar 

  32. Mogensen CE, Christensen CK, Mau Pedersen M, Alberti KGMM, Boye N, Christensen T, Christiansen JS, Flyvbjerg A, Ingerslev J, Schmitz A, Ørskov H. Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabetic Complications 1990; 4: 159–165.

    Article  CAS  Google Scholar 

  33. Mau Pedersen M, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycemic control. Clin Sci 1992; 83: 445–451.

    Google Scholar 

  34. Marre M, Dubin T, Hallab M, Berrut G, Bouhanick B, Lejeune J-J, Fressinaud P. Different renal response to hyperglycemia in insulin-dependent diabetics at risk for, or protected against diabetic nephropathy. Diabetes 1993; 42: A423.

    Google Scholar 

  35. Skøtt P, Vaag A, Hother-Nielsen O, Andersen P, Bruun NE, Giese J, Beck-Nielsen H, Parving H-H. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 715–727.

    Article  PubMed  Google Scholar 

  36. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599–606.

    Article  PubMed  CAS  Google Scholar 

  37. Mau Pedersen M, Christiansen JS, Mogensen CE. Reduction of glomerular hyper-filtration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition. Diabetes 1991; 40: 527–531.

    Article  Google Scholar 

  38. Passariello N, Sepe J, Marrazzo G, De Cicco A, Peluso A, Pisano MCA, Sgambato S, Tesauro P, D’Onofrio F. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate in IDDM subjects with nephropathy. Diabetes Care 1993; 16: 789–795.

    Article  PubMed  CAS  Google Scholar 

  39. Trevisan R, Nosadini R, Fioretto P, Avogaro A, Duner E, Iori E, Valerio A, Doria A, Crepaldi G. Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin dependent) diabetes. Diabetologia 1987; 30: 214–221.

    Article  PubMed  CAS  Google Scholar 

  40. Trevisan R, Nosadini R, Fioretto P, Avogaro A, Duner E, Iori E, Valerio A, Doria A, Crepaldi G. Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin dependent) diabetes. Diabetologia 1987; 30: 214–221.

    Article  PubMed  CAS  Google Scholar 

  41. Skøtt P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving H-H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989; 32: 694–699.

    Article  PubMed  Google Scholar 

  42. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 1987; 80: 670–674.

    Article  PubMed  CAS  Google Scholar 

  43. Haneda M, Kikkawa R, Sakamoto K, Nakanishi S, Matsuda Y, Shigeta Y. Amelioration of glomerular hyperfiltration and hyperperfusion in diabetic rats by non-peptide antagonist for atrial natriuretic peptide receptors. Diabetes 1993; 42: A284.

    Google Scholar 

  44. Christiansen JS, Gammelgaard J, Frandsen M, Ørskov H, Parving H-H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981; 11: 487–490.

    Article  PubMed  CAS  Google Scholar 

  45. Parving H-H, Christiansen JS, Noer I, Tronier B, Mogensen CE. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia 1980; 19: 350–354.

    Article  PubMed  CAS  Google Scholar 

  46. Hoogenberg K, Dullaart RPF, Freling NJM, Meijer S, Sluiter WJ. Contributory roles of glycated haemoglobin, circulatory glucagon and growth hormone to increased renal haemodynamics in type 1 (insulin-dependent) diabetes mellitus (abstract). Eur J Clin Invest 1993; 23: A42.

    Google Scholar 

  47. Flyvbjerg A. The role of insulin-like growth factor I in initial renal hypertrophy in experimental diabetes. In: Flyvbjerg A, Ørskov H, Alberti KGMM (eds). Growth Hormone and Insulin-Like Growth Factor I. John Wiley & Sons Ltd. 1993; pp. 271–306.

    Google Scholar 

  48. Castellino P, Hunt W, DeFronzo RA. Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. Kidney Int 1987; 32: S-15–S-20.

    Article  Google Scholar 

  49. Mau Pedersen M, Mogensen CE, Schönau Jørgensen F, Møller B, Lykke G, Pedersen O. Renal effects from limitation of high dietary protein in normoalbuminuric diabetic patients. Kidney Int 1989; 36: S-115–S-121.

    Google Scholar 

  50. Jones MG, Lee K, Swaminathan R. The effect of dietary protein on glomerular filtration rate in normal subjects. Clin Nephrol 1987; 27: 71–75.

    PubMed  CAS  Google Scholar 

  51. Kraus ES, Cheng L, Sikorski I, Spector DA. Effects of phosphorus restriction on renal response to oral and intravenous protein loads in rats. Am J Physiol 1993; 264: F752–F759.

    Google Scholar 

  52. Wang YX, Brooks DP. The role of adenosine in glycine-induced glomerular hyper-filtration in rats. J Pharmacol Exp Ther 1992; 263: 1188–1194.

    PubMed  CAS  Google Scholar 

  53. Angielski S, Redlak M, Szczepanska KM. Intrarenal adenosine prevents hyperfiltration induced by atrial natriuretic factor. Miner Electrolyte Metab 1990; 16: 57–60.

    PubMed  CAS  Google Scholar 

  54. Wang YX, Gellai M, Brooks DP. Dopamine DAI receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats. Am J Physiol 1992; 262: F1055-F1060.

    Google Scholar 

  55. Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK. Evidence for renal kinins as mediators of amino acid-induced hyperfusion and hyperfiltration in the rat. J Clin Invest 1992; 89: 1460–1468.

    Article  PubMed  CAS  Google Scholar 

  56. Friedlander G, Blanchet BF, Nitenberg A, Laborie C, Assan R, Amiel C. Glucagon secretion is essential for aminoacid-induced hyperfiltration in man. Nephrol Dial Transplant 1990; 5: 110–117.

    Article  PubMed  CAS  Google Scholar 

  57. Hostetter TH. Diabetic nephropathy. Metabolic versus hemodynamic considerations. Diabetes Care 1992; 15: 1205–1215.

    Article  PubMed  CAS  Google Scholar 

  58. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986; 46: 201–206.

    Article  PubMed  CAS  Google Scholar 

  59. Rudberg S, Persson B, Dalqvist G. Increased glomerular filtration rate predicts diabetic nephropathy-results form an 8 year prospective study. Kidney Int 1992; 41: 822–828.

    Article  PubMed  CAS  Google Scholar 

  60. Lervang H-H, Jensen S, Brøchner-Mortensen J, Ditzel J. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Diabetic Med 1992; 9: 635–640.

    Article  PubMed  CAS  Google Scholar 

  61. Jones SL, Wiseman MJ, Viberti GC. Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 1991; 34: 59–60.

    Article  PubMed  CAS  Google Scholar 

  62. Schmieder RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 1990; 264: 2775–2780.

    Article  PubMed  CAS  Google Scholar 

  63. Mau Pedersen M, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Ørskov H. Acute effects of a somatostatin analogue on kidney function in type i diabetic patients. Diabetic Med 1990; 7: 304–309.

    Article  Google Scholar 

  64. Serri O, Beauregard H, Brazeau P, Abribat T, Lamber J, Harris A, Vachon L. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265; 888–892.

    Article  PubMed  CAS  Google Scholar 

  65. Mau Pedersen M, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Med 1988; 5: 562–569.

    Article  Google Scholar 

  66. Ichikawa I, Harris RC. Angiotensin actions in the kidney: Renewed insight into the old hormone (Editorial Review). Kidney Int 1991; 40: 583–596.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Margrethe Mau Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Department M (Diabetes & Endocrinology) Aarhus Kommunehospital, University Hospitals in Aarhus, Aarhus C, Denmark

    Carl Erik Mogensen

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pedersen, M.M. (1994). Early Renal Hyperfunction and Hypertrophy in IDDM Patients Including Comments on Early Intervention. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6746-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6746-9_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6748-3

  • Online ISBN: 978-1-4757-6746-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation